Daluyon, Jenmea A.
HRN: 26-78-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/15/2025
03/21/2025
TOPICAL
100u
QID
Oral Thrush
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes